Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01040000
What this trial is testing

QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer

Who this might be right for
Metastatic Pancreatic CancerMetastatic Colorectal Cancer
Precision Biologics, Inc 94
Testing effectiveness (Phase 2)WithdrawnNCT00002664
What this trial is testing

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
James Ahlgren
Testing effectiveness (Phase 2)UnknownNCT05143099
What this trial is testing

Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC

Who this might be right for
Colorectal Neoplasms
Shanghai Zhongshan Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT05039944
What this trial is testing

SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System Malignancies

Who this might be right for
Colorectal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 7
Large-scale testing (Phase 3)Active Not RecruitingNCT04607421
What this trial is testing

Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Pfizer 841
Early research (Phase 1)Ended earlyNCT03145909
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 19
Early research (Phase 1)Ended earlyNCT03948763
What this trial is testing

MRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001)

Who this might be right for
NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms+1 more
Merck Sharp & Dohme LLC 70
Not applicableStudy completedNCT03698253
What this trial is testing

Metastatic Colorectal Cancer Treated With Regorafenib and FOLFIRI

Who this might be right for
Colorectal Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital 41
Not applicableStudy completedNCT03563651
What this trial is testing

Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers

Who this might be right for
Stage III Colorectal Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8+5 more
University of Southern California 29
Testing effectiveness (Phase 2)Ended earlyNCT04166383
What this trial is testing

VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+2 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)UnknownNCT04777162
What this trial is testing

Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer

Who this might be right for
Gastric CancerColo-rectal Cancer
Peking University 40
Not applicableUnknownNCT06177288
What this trial is testing

DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Neoplasms
Fudan University 39
Early research (Phase 1)Study completedNCT00098982
What this trial is testing

Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 16
Large-scale testing (Phase 3)Study completedNCT01103323
What this trial is testing

Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Who this might be right for
Metastatic Colorectal Cancer
Bayer 760
Testing effectiveness (Phase 2)Study completedNCT02821559
What this trial is testing

Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon 37
Testing effectiveness (Phase 2)UnknownNCT03457896
What this trial is testing

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Who this might be right for
Metastatic Colorectal Cancer
NSABP Foundation Inc 35
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Not applicableStudy completedNCT01674907
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 27
Not applicableUnknownNCT04831528
What this trial is testing

Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study

Who this might be right for
Metastatic Colorectal Cancer
Fudan University 100
Not applicableWithdrawnNCT01941173
What this trial is testing

Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center
Next Page